ÂÜÀòÂÒÂ×

Thomas Neumann has an extensive background in the pharmaceutical industry, with a strong focus on technology transfer, launch planning, and project management. Thomas has held various leadership positions at companies such as Boehringer Ingelheim, Sanofi, NovAliX, and Graffinity Pharmaceuticals. Thomas has a deep expertise in biophysical drug discovery, screening, and interactions within the therapeutic areas of Cardio Renal Metabolism. Their education includes a Doctor of Philosophy in Physical Chemistry and postdoctoral research in Biophysics/Biochemistry.